Gastroesophageal reflux and serum biomarkers in systemic sclerosis-associated interstitial lung disease: comment on the article by Elhai et al Reply

被引:0
|
作者
Elhai, Muriel [1 ,2 ]
Hoffmann-Vold, Anna Maria [3 ,4 ]
Allanore, Yannick [1 ,2 ]
机构
[1] Paris Descartes Univ, Cochin Inst, INSERM U1016, UMR8104, Paris, France
[2] Paris Descartes Univ, Cochin Hosp, Paris, France
[3] Oslo Univ Hosp, Oslo, Norway
[4] Univ Oslo, Inst Clin Med, Oslo, Norway
关键词
D O I
10.1002/art.40908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1204 / 1206
页数:3
相关论文
共 50 条
  • [41] Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease
    Sari, Alper
    Onder, Omer
    Armagan, Berkan
    Bolek, Ertugrul Cagri
    Farisogullari, Bayram
    Bilgin, Emre
    Yardimci, Gozde Kubra
    Ariyurek, Macit
    Akdogan, Ali
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 83 - 88
  • [42] Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease
    Silver, Richard M.
    Feghali-Bostwick, Carol A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 485 - 487
  • [43] Current treatment of systemic sclerosis-associated interstitial lung disease
    Bes, Cemal
    Cetinkaya, Erdogan
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (01): : 85 - 92
  • [44] Additional points to consider before incorporating the Food and Drug Administration-approved therapies for systemic sclerosis-associated interstitial lung disease: comment on the article by Khanna et al
    Bredemeier, Markus
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (04) : 733 - 734
  • [45] Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort
    Roth, Eliane
    Bruni, Cosimo
    Petelytska, Liubov
    Becker, Mike Oliver
    Dobrota, Rucsandra
    Jordan, Suzana
    Mihai, Carina
    Muraru, Sinziana
    Carreira, Patricia E.
    De Vries-Bouwstra, Jeska
    Braun-Moscovici, Yolanda
    Liakouli, Vasiliki
    Moroncini, Gianluca
    Bergmann, Christina
    Mouthon, Luc
    Denton, Christopher P.
    De Santis, Maria
    Cauli, Alberto
    Adler, Sabine
    Bernardino, Vera
    Truchetet, Marie-Elise
    Vonk, Madelon
    Del Galdo, Francesco
    Hoffmann-Vold, Anna-Maria
    Distler, Oliver
    Elhai, Muriel
    RHEUMATOLOGY, 2025,
  • [46] Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease
    Huang, Biqing
    Li, Jing
    Zhao, Jiuliang
    ARCHIVES OF RHEUMATOLOGY, 2021, 36 (04) : 548 - 559
  • [47] Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease
    Matson, S.
    Dvorkin, D.
    Fischer, A.
    Achtar-Zadeh, N.
    Wolters, P. J.
    Lee, J. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [48] Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
    Stock, Carmel J. W.
    Hoyles, Rachel K.
    Daccord, Cecile
    Kokosi, Maria
    Visca, Dina
    De Lauretis, Angelo
    Alfieri, Veronica
    Kouranos, Vasilis
    Margaritopoulos, George
    George, Peter M.
    Molyneaux, Philip L.
    Chua, Felix
    Maher, Toby M.
    Abraham, David J.
    Ong, Voon
    Donovan, Jackie
    Sestini, Piersante
    Denton, Christopher P.
    Wells, Athol U.
    Renzoni, Elisabetta A.
    RESPIROLOGY, 2021, 26 (05) : 461 - 468
  • [49] Microchimerism in systemic sclerosis: comment on the article by Johnson et al - Reply
    Johnson, KL
    Bianchi, DW
    Nelson, JL
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2538 - 2539
  • [50] Decreased serum cathepsin S levels in patients with systemic sclerosis-associated interstitial lung disease
    Toyama, Satoshi
    Yamashita, Takashi
    Saigusa, Ryosuke
    Miura, Shunsuke
    Nakamura, Kouki
    Hirabayashi, Megumi
    Miyagawa, Takuya
    Fukui, Yuki
    Omatsu, Jun
    Yoshizaki, Ayumi
    Sato, Shinichi
    Asano, Yoshihide
    JOURNAL OF DERMATOLOGY, 2020, 47 (09): : 1027 - 1032